Rogel Cancer Center team gets $2M grant to train researchers in cancer care delivery

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

University of Michigan Rogel Cancer Center researchers received a $2 million grant from NCI to prepare the next generation of scientists focused on cancer care delivery.

This new training program focuses on preparing pre- and postdoctoral trainees from diverse disciplines to become independent investigators researching how cancer care is delivered and how to improve the care experience for patients with cancer.

“Recent advances in cancer therapies may be irrelevant if they cannot be given in a safe, effective, efficient, equitable and patient-centered manner across diverse treatment settings. We need more researchers to help discover care gaps, develop and test efficacious interventions, and implement discoveries into routine clinical practice,” principal investigator Christopher Friese, associate director for cancer control and population sciences at the Rogel Cancer Center and Elizabeth Tone Hosmer Professor of Nursing at the U-M School of Nursing, said in a statement.

The grant will fund a total of three predoctoral and fourteen postdoctoral students. With the support of their mentors, formal coursework, selected emphasis activities and professional socialization, trainees will acquire skills in descriptive discovery research, intervention development and testing, and implementation science to address gaps in the field.

The first predoctoral student and initial four postdoctoral students have been selected and will begin their training July 1.

Table of Contents

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login